法律
条约
判决书
按司法管辖区搜索
Order Amending Schedule 1 to the Patent Act (2014-1) (SOR/2015-154), 加拿大
返回
WIPO Lex中的最新版
版本年份
2014
日期
生效:
2015年6月17日
议定:
2015年6月17日
主题事项
实施规则/实施细则
文本类型
专利(发明)
备注
The notification by Canada to the WTO under Article 63.2 of TRIPS states:
'The Order Amending Schedule 1 to the Patent Act (2014-1) adds the following names of three additional HIV/AIDS treatments to Schedule 1 to the Patent Act:
- 'efavirenz + emtricitabine + tenofovir disoproxil' in tablet form and in the specified strength of 600 mg, 200 mg, and 300 mg, respectively;
- 'emtricitabine + tenofovir disoproxil' in tablet form and in the specified strength of 200 mg, and 300 mg, respectively; and
- 'tenofovir disoproxil' in tablet form and in the specified strength of 300 mg.
The Decision of the General Council of 30 August 2003 allows WTO member countries with pharmaceutical manufacturing capacity to authorize the non-consensual use of a patented invention (i.e. compulsory licences) to manufacture and export generic versions of patented drugs and medical devices to developing countries without the capacity to manufacture the products themselves.
Canada's Access to Medicines Regime (CAMR) implements the 30 August 2003, decision by permitting the grant of 'export-only' compulsory licences to Canadian pharmaceutical manufacturers who wish to supply drugs and medical devices to countries unable to manufacture their own. The products that are eligible for export under CAMR are listed on Schedule 1 of the Patent Act. When CAMR received Royal Assent in May 2004, Schedule 1 was primarily composed of the pharmaceutical products on the World Health Organization's Model List of Essential Medicines (EML) that were patented in Canada. The EML represents the minimum medicine needs for a basic health-care system and, at the time, provided a baseline to ensure that CAMR was able to meet the basic healthcare needs of developing and least-developed countries in a clear and transparent manner.'
现有文本
主要文本
主要文本
英语
Order Amending Schedule 1 to the Patent Act (2014-1) (SOR/2015-154)
PDF
HTML
法语
Décret modifiant l’annexe 1 de la loi sur les brevets (2014-1) (DORS/1015-154)
PDF
HTML
立法
修正 (1 文本(小))
修正 (1 文本(小))
世贸组织文件号
IP/N/1/CAN/16
IP/N/1/CAN/P/12
WIPO Lex序号
CA198